Prilenia Therapeutics
Developing New Treatments for Neurodegenerative Diseases
Active
B
Startup
Yakum
Founded 2018-05
Prilenia is a late clinical-stage biotechnology company founded in 2018 focused on the urgent mission to develop novel therapeutics to address the progression of neurodegenerative diseases and neurodevelopmental disorders. The initial focus of the company has been on Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). Prilenia's lead compou…
SectorHealth Tech & Life Sciences
StageB
Total raised$144.5M
Employees56
Founded2018-05
HQYakum
Crunchbaseprilenia
Patents1
Confidence99
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals